Recombinant Anopheles gambiae Mediator of RNA polymerase II transcription subunit 27 (MED27)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
MED27; AGAP002664Mediator of RNA polymerase II transcription subunit 27; Mediator complex subunit 27
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-295
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Anopheles gambiae (African malaria mosquito)
Target Names
MED27
Target Protein Sequence
MNLEPINNAL SQLRVLRSSV GQVFETLGTG VRADHGEEGK EQKFLQELQE LLNSVNANLK DFESCINDLT PPQTPLTLAN SAYLSLETNL ERQALYPHLV QSYKWHDKLH EYSTFASTLL QQNSLKRSYY TNTKRRRSLP SSHLATPQMV ENLIGSIHYN NMNLKIARPF MTNAILHITI ARVLRAAVIL KGLLIEWVTV KGYEESLLDG VDEQWTESRH QVFRKVQDHA HSAMLHFFSP TLPELAIRSF ITWFRSYVTL FADPCKKCGK HLHNTLPPTW RDLRTLEPFH EECKQ
Uniprot No.

Target Background

Function
Recombinant Anopheles gambiae Mediator of RNA polymerase II transcription subunit 27 (MED27) is a component of the Mediator complex, a coactivator essential for the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator acts as a bridge, transmitting information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. It is recruited to promoters through direct interactions with regulatory proteins, serving as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and general transcription factors.
Database Links
Protein Families
Mediator complex subunit 27 family
Subcellular Location
Nucleus.

Q&A

What is MED27 and what is its role in transcriptional regulation?

MED27 is a component of the Mediator complex, which serves as a bridge between transcription factors and RNA polymerase II. The Mediator complex is essential for transcription initiation and regulation of gene expression. In particular, MED27 is part of the head module of the Mediator complex and interacts extensively with multiple subunits, including MED17 . The C-terminal domain of MED27 contains a C2-H2 zinc finger motif that is critical for its function . This structural feature suggests that MED27 may be directly involved in protein-protein or protein-DNA interactions during transcriptional processes.

In A. gambiae, as in other organisms, MED27 likely contributes to the regulation of various developmental and physiological processes through its role in transcriptional control. Understanding its precise function in mosquitoes requires examining both conserved mechanisms of Mediator function and species-specific adaptations.

How conserved is MED27 across different species?

MED27 is highly conserved across diverse eukaryotic species, suggesting its fundamental importance in transcriptional regulation. In humans, variants in MED27 have been associated with developmental delay and neurological disorders, indicating its essential role in development .

The C-terminal region of MED27 appears to be particularly conserved, as evidenced by the clustering of disease-causing missense variants in humans near the C-terminus . In studies involving fruit flies, homozygous C-terminal mutations of Med27 were lethal, further demonstrating the critical importance of this domain .

For researchers studying A. gambiae MED27, sequence alignment analysis with MED27 from other insect species, as well as more distant relatives like humans, can provide insights into conserved functional domains. Regions with high sequence conservation likely represent domains essential for core Mediator complex functions, while more divergent regions may reflect species-specific adaptations.

What are the structural characteristics of A. gambiae MED27?

While the specific structural details of A. gambiae MED27 are not explicitly described in the available research, inferences can be made based on conserved features observed in other species. The C-terminal domain, which contains a C2-H2 zinc finger motif in humans, is likely to be present in the A. gambiae protein as well . This domain is crucial for protein-protein interactions within the Mediator complex.

To characterize the structure of A. gambiae MED27, researchers should consider approaches such as:

  • Homology modeling based on known structures from other species

  • Protein domain prediction using bioinformatic tools

  • Experimental structure determination through X-ray crystallography or cryo-electron microscopy

  • Protein-protein interaction studies to map the association with other Mediator subunits

What are the best approaches for expressing recombinant A. gambiae MED27?

Expressing recombinant A. gambiae MED27 requires careful consideration of expression systems and purification strategies. Based on general recombinant protein methodology and the nature of transcription factors, the following approaches are recommended:

  • Expression Systems Selection:

    • Bacterial systems (E. coli): Use BL21(DE3) or Rosetta strains with pET vectors for initial attempts

    • Insect cell systems (Sf9, Sf21): Consider baculovirus expression for improved folding of eukaryotic proteins

    • Cell-free expression: Useful for difficult-to-express proteins or when rapid screening is needed

  • Optimization Strategies:

    • Codon optimization for the expression host

    • Fusion tags (His6, GST, MBP) to improve solubility and facilitate purification

    • Expression at lower temperatures (16-20°C) to enhance proper folding

    • Co-expression with chaperones if protein aggregation occurs

  • Purification Approaches:

    • Affinity chromatography using the fusion tag

    • Ion exchange chromatography based on the predicted isoelectric point

    • Size exclusion chromatography for final polishing and to assess oligomeric state

When attempting to express the full-length protein proves challenging, a domain-based approach focusing on the conserved C-terminal region might be more successful, as this domain appears to be functionally critical based on human studies .

How can researchers effectively study MED27 interactions with other Mediator complex subunits?

Understanding MED27's interactions within the Mediator complex is crucial for elucidating its function. Several methodological approaches can be employed:

  • Co-immunoprecipitation (Co-IP):

    • Generate antibodies against A. gambiae MED27 or use epitope-tagged recombinant protein

    • Pull down MED27 from mosquito cell lysates and identify interacting partners

    • Confirm interactions with reciprocal Co-IP experiments

  • Yeast Two-Hybrid Screening:

    • Use MED27 as bait to screen for interactions with other A. gambiae proteins

    • Validate positive hits with alternative methods

    • Focus particularly on potential interactions with MED17, which is known to interact with MED27 in other species

  • Proximity Labeling Methods:

    • Employ BioID or APEX2 fusion proteins to identify proximal proteins in living cells

    • This approach can detect both stable and transient interactions

  • Cryo-electron Microscopy:

    • Attempt to purify intact Mediator complex from A. gambiae

    • Determine the structure and position of MED27 within the complex

    • Compare with known structures from other species

Based on studies in other organisms, particular attention should be paid to interactions between MED27 and MED17, as this interaction appears to be functionally significant .

What RNAi approaches are most effective for studying MED27 function in A. gambiae?

RNA interference (RNAi) is a powerful tool for studying gene function in A. gambiae. Based on successful RNAi approaches used for other salivary gland genes in A. gambiae , the following strategies are recommended for MED27:

  • dsRNA Design and Synthesis:

    • Design 300-500 bp dsRNA fragments targeting specific regions of MED27

    • Include non-overlapping fragments to control for off-target effects

    • Synthesize using in vitro transcription with T7 RNA polymerase

  • Delivery Methods:

    • Microinjection into the thorax of adult female mosquitoes

    • Ensure precise timing relative to blood-feeding experiments

    • Consider hemocoel injection for broader distribution

  • Validation of Knockdown:

    • Quantitative RT-PCR to measure reduction in MED27 transcript levels

    • Western blot analysis (if antibodies are available) to confirm protein reduction

    • Include appropriate controls (GFP dsRNA is commonly used)

  • Phenotypic Analysis:

    • Assess developmental phenotypes

    • Evaluate transcriptional changes of known target genes

    • Monitor survival, fecundity, and blood-feeding behavior (as performed for other salivary gland genes)

Previous studies have successfully used RNAi to silence salivary gland genes including D7L2, anophelin, peroxidase, and the SG2 precursor, demonstrating measurable phenotypic effects on blood-feeding behavior .

How does MED27 contribute to tissue-specific gene expression in A. gambiae?

Investigating the tissue-specific roles of MED27 requires sophisticated approaches to determine its differential activity across mosquito tissues:

  • Tissue-Specific Transcriptome Profiling:

    • Compare MED27 expression levels across tissues using RNA-seq

    • Correlate MED27 expression with tissue-specific transcriptional programs

    • The salivary gland transcriptome comprises approximately 38% of the total mosquito transcriptome , suggesting specialized transcriptional regulation

  • Chromatin Immunoprecipitation Sequencing (ChIP-seq):

    • Perform ChIP-seq with anti-MED27 antibodies in different tissues

    • Identify tissue-specific binding sites and associated genes

    • Compare binding patterns before and after blood-feeding

  • Tissue-Specific RNAi:

    • Develop methods for tissue-restricted knockdown of MED27

    • Compare transcriptional consequences across tissues

    • Assess developmental and physiological phenotypes

  • Protein Complex Analysis:

    • Investigate tissue-specific Mediator complex composition

    • Determine if MED27 associates with different cofactors in different tissues

    • Look for tissue-specific post-translational modifications

The significant changes in salivary gland gene expression observed after blood-feeding suggest that dynamic transcriptional regulation occurs in this tissue, potentially involving MED27-mediated mechanisms.

What is the relationship between MED27 function and blood-feeding-induced transcriptional changes?

Blood-feeding induces significant transcriptional changes in A. gambiae salivary glands, with 52 transcripts up-regulated and 41 down-regulated within two hours of feeding . Understanding MED27's role in this process requires:

  • Temporal Analysis:

    • Compare MED27 recruitment to promoters before and after blood-feeding using ChIP-seq

    • Perform time-course analysis of transcriptional changes

    • Track MED27 protein levels and modifications during the feeding response

  • Target Gene Analysis:

    • Identify overlap between MED27-regulated genes and blood-feeding-responsive genes

    • Focus on genes encoding known anti-hemostatic factors (D7L2, anophelin, peroxidase)

    • Determine if MED27 preferentially regulates genes involved in specific pathways

  • Functional Validation:

    • Perform MED27 knockdown specifically timed to coincide with blood-feeding

    • Assess impact on blood-feeding-induced transcriptional changes

    • Measure functional consequences for feeding behavior and success

  • Signaling Pathway Integration:

    • Investigate how signaling pathways activated by blood-feeding interact with MED27

    • Examine potential post-translational modifications of MED27 in response to feeding

    • Identify transcription factors that might recruit MED27 to feeding-responsive genes

How does the function of MED27 in A. gambiae compare with its role in other disease vectors?

Comparative analysis of MED27 across vector species can provide insights into both conserved functions and species-specific adaptations:

  • Comparative Genomics Approach:

    • Perform sequence and structural comparisons of MED27 across vector species

    • Identify conserved domains and species-specific variations

    • Map known mutations/variations to protein structures

  • Functional Conservation Testing:

    • Conduct cross-species complementation experiments

    • Express MED27 from other vectors in A. gambiae background after RNAi depletion

    • Assess rescue of molecular and phenotypic defects

  • Evolutionary Analysis:

    • Calculate selection pressures on different domains of MED27

    • Identify regions under positive selection that might reflect species-specific adaptations

    • Correlate evolutionary patterns with vector-specific biology

  • Comparative Transcriptomics:

    • Compare MED27-regulated gene networks across vector species

    • Identify conserved and divergent target genes

    • Relate differences to vector-specific traits and pathogen interactions

What is the potential role of MED27 in malaria transmission?

As a transcriptional regulator in A. gambiae, MED27 may influence malaria transmission through several mechanisms:

  • Salivary Gland Gene Regulation:

    • MED27 may regulate genes involved in blood-feeding, which is critical for parasite transmission

    • Salivary gland genes like D7L2, anophelin, and peroxidase facilitate blood-feeding by preventing platelet aggregation, blood clotting, and inflammatory responses

    • Altered expression of these genes affects probing time and feeding success

  • Immune Response Regulation:

    • Transcriptional regulation of immune-related genes could impact parasite development

    • The salivary gland expresses immune genes that may interact with Plasmodium sporozoites

    • MED27 might influence the mosquito's ability to kill or support parasite development

  • Developmental Timing:

    • Given MED27's role in development in other species , it may influence mosquito life stages relevant to vectorial capacity

    • Developmental timing and reproductive success affect vector population dynamics

  • Experimental Approaches:

    • RNAi-based silencing of MED27 followed by Plasmodium infection studies

    • Transcriptome analysis of parasite-infected mosquitoes with modified MED27 expression

    • Spatial and temporal analysis of MED27 expression during parasite development

Could targeting MED27 be a viable approach for vector control strategies?

The potential of MED27 as a target for vector control depends on several factors:

  • Essentiality Assessment:

    • Determine if complete MED27 knockdown is lethal in A. gambiae

    • Assess effects of partial knockdown on mosquito fitness and vectorial capacity

    • Evaluate compensation mechanisms and redundancy

  • Life Stage Specificity:

    • Investigate MED27 function across different mosquito life stages

    • Target intervention to stages most relevant for transmission

    • Consider impacts on non-target organisms with homologous proteins

  • Delivery Mechanisms:

    • Design transgenic approaches for conditionally disrupting MED27 function

    • Develop RNAi-based methods that could be deployed in the field

    • Consider small molecule inhibitors that could disrupt specific MED27 interactions

  • Resistance Management:

    • Assess potential for resistance development

    • Target conserved regions less likely to tolerate mutations

    • Consider combination approaches targeting multiple components of the transcriptional machinery

Given that MED27 mutations in other organisms can lead to developmental defects and embryonic lethality , disrupting its function could potentially reduce vector populations or transmission capacity.

What are the challenges in generating antibodies against A. gambiae MED27?

Developing specific antibodies against A. gambiae MED27 presents several challenges:

  • Antigen Design Considerations:

    • Select unique epitopes with low homology to other mosquito proteins

    • Focus on surface-exposed regions predicted by structural analysis

    • Consider both full-length protein and peptide-based approaches

    • The C-terminal domain may be particularly important for function and could be targeted

  • Production Strategies:

    • Express recombinant fragments in E. coli or insect cells

    • Ensure proper folding of conformational epitopes

    • Purify under native conditions when possible

  • Antibody Validation Requirements:

    • Test for cross-reactivity with other Mediator subunits

    • Validate specificity using RNAi-depleted samples

    • Confirm utility in multiple applications (Western blot, immunoprecipitation, ChIP)

  • Application-Specific Optimization:

    • For ChIP applications, optimize fixation conditions

    • For immunolocalization, determine appropriate fixation and permeabilization protocols

    • For co-immunoprecipitation, establish conditions that maintain protein-protein interactions

What reporter systems can be developed to study MED27-dependent transcriptional regulation?

Developing reporter systems to study MED27-mediated transcription in A. gambiae requires:

  • Reporter Design:

    • Identify putative MED27-responsive promoters from transcriptomic data

    • Clone promoter regions upstream of luciferase or fluorescent protein genes

    • Include wild-type and mutated versions of binding sites

  • Delivery Systems:

    • Establish stable cell lines derived from A. gambiae tissues

    • Develop transient transfection protocols for primary mosquito cells

    • Consider in vivo reporter systems using transgenic approaches

  • Experimental Paradigms:

    • Measure reporter activity after MED27 knockdown or overexpression

    • Assess responsiveness to stimuli that trigger transcriptional changes (e.g., blood-feeding)

    • Perform structure-function analysis using mutated versions of MED27

  • Advanced Applications:

    • Develop split reporter systems to study protein-protein interactions

    • Create inducible systems to control MED27 activity

    • Design multiplexed reporters to monitor multiple promoters simultaneously

How can CRISPR/Cas9 technology be optimized for studying MED27 function in A. gambiae?

CRISPR/Cas9 technology offers powerful approaches for studying MED27 function:

  • Gene Editing Strategies:

    • Design guide RNAs targeting conserved domains of MED27

    • Create knock-in alleles with epitope tags for tracking endogenous protein

    • Generate domain-specific deletions to assess functional contributions

    • Develop conditional knockout systems using tissue-specific promoters

  • Delivery Methods:

    • Optimize embryo microinjection protocols

    • Establish parameters for successful editing in A. gambiae

    • Consider alternative delivery systems for adult mosquitoes

  • Screening and Validation:

    • Design efficient screening strategies for identifying edited individuals

    • Establish molecular validation protocols

    • Confirm absence of off-target effects

  • Phenotypic Analysis:

    • Design comprehensive phenotyping approaches

    • Assess developmental timing, morphology, and viability

    • Evaluate vector competence and transmission potential

The successful application of CRISPR/Cas9 for gene editing in Plasmodium parasites provides a methodological framework that could be adapted for A. gambiae studies.

Comparative Analysis Table: MED27 Across Species

SpeciesMED27 ConservationKey Functional DomainsPhenotypes of DisruptionKey Interacting PartnersResearch Methods Used
HumansReferenceC-terminal domain with C2-H2 zinc finger motif Developmental delay, dystonia, psychomotor delay, seizures MED17 Exome sequencing, variant filtering
DrosophilaHighC-terminal domainEmbryonic lethality Not specified in sourcesNot specified in sources
A. gambiaeNot specified in sourcesPredicted C-terminal domainNot directly studiedPredicted: MED17 and other Mediator subunitsTranscriptomics approaches

What emerging technologies could advance our understanding of MED27 function?

Several cutting-edge technologies hold promise for deeper insights into MED27 function:

  • Single-Cell Transcriptomics:

    • Characterize cell-type-specific MED27 activity

    • Identify rare cell populations with unique MED27-dependent transcriptional programs

    • Track transcriptional changes in real-time after stimuli

  • Proximity Labeling Proteomics:

    • Map the dynamic interactome of MED27 under different conditions

    • Identify tissue-specific interaction partners

    • Discover novel components of transcriptional complexes

  • In situ Transcriptomics:

    • Visualize MED27-dependent transcription with spatial resolution

    • Correlate transcriptional activity with tissue architecture

    • Identify microenvironments with distinct regulatory patterns

  • Cryo-Electron Tomography:

    • Visualize native Mediator complexes in cellular contexts

    • Determine structural changes upon activation or repression

    • Identify conformational states relevant to different regulatory outcomes

  • Integrative Multi-Omics:

    • Combine transcriptomics, proteomics, and metabolomics data

    • Model system-wide effects of MED27 perturbation

    • Identify key nodes in regulatory networks

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.